Related Experiment Videos
Estimating prevalence when the true disease status is incompletely ascertained
1Department of Mathematics, Statistics and Epidemiology, Imperial Cancer Research Fund, 61 Lincoln's Inn Fields, London WC2A 3PX, UK. p.sasieni@icrf.icnet.uk
Statistics in Medicine
|March 17, 2001
Summary
This study addresses challenges in estimating undetected disease cases from screening test studies where not everyone gets fully diagnosed. It proposes methods to adjust for incomplete evaluations and missed cases, improving diagnostic accuracy.
Area of Science:
- Epidemiology
- Biostatistics
- Medical Diagnostics
Background:
- Estimating true disease prevalence is crucial for public health interventions.
- Screening tests are widely used but can lead to underestimation of disease due to incomplete diagnostic follow-up.
- Incomplete evaluation of individuals, particularly those testing negative, poses a significant challenge in accurately assessing screening test performance.
Purpose of the Study:
- To develop and discuss methods for adjusting case counts in screening studies with incomplete diagnostic evaluations.
- To address the underestimation of disease prevalence and test sensitivity caused by unreferred individuals and undetected cases among negatives.
- To propose an analytical framework for studies involving three or more screening tests.
Main Methods:
- Statistical adjustment for individuals not fully evaluated after positive screening tests.
- Methods to account for undetected cases among individuals testing negative on all screening tests.
- Procedures for estimating disease prevalence and test sensitivity using a random sample of negatives in multi-test screening scenarios.
Main Results:
- The study provides a framework for adjusting for biases introduced by incomplete diagnostic evaluations in screening studies.
- It offers methods to correct for missed cases among both positive and negative screening results.
- The proposed methods enhance the accuracy of disease prevalence and test sensitivity estimations.
Conclusions:
- Accurate estimation of disease prevalence and screening test performance requires accounting for incomplete diagnostic evaluations.
- The proposed adjustments are essential for valid inference in multi-test screening studies.
- The methodology facilitates more reliable public health assessments based on screening program data.